Hurum Co., Ltd. (KOSDAQ:353190)
South Korea · Delayed Price · Currency is KRW 2,600.00
-5.00 (-0.19%)
At close: May 29, 2026
Hurum Revenue
Hurum had revenue of 23.05B KRW in the quarter ending March 31, 2026, a decrease of -8.56%. This brings the company's revenue in the last twelve months to 96.85B, up 0.09% year-over-year. In the year 2025, Hurum had annual revenue of 99.01B with 0.86% growth.
Revenue (ttm)
96.85B
Revenue Growth
+0.09%
P/S Ratio
0.21
Revenue / Employee
706.96M
Employees
137
Market Cap
20.48B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 99.01B | 845.62M | 0.86% |
| Dec 31, 2024 | 98.17B | 9.76B | 11.04% |
| Dec 31, 2023 | 88.41B | 21.50B | 32.13% |
| Dec 31, 2022 | 66.91B | -2.17B | -3.14% |
| Dec 31, 2021 | 69.08B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GeneBioTech Co. ,Ltd | 89.44B |
| ChoA Pharmaceutical Co., LTD. | 59.62B |
| WooGene B&G | 54.75B |
| CXI Healthcare Technology Group | 54.16B |
| Seoul Pharma | 51.33B |
| Kwangdong Healthbio | 38.10B |
| Union Korea Pharm | 29.66B |
| Daesung Microbiological Labs. | 25.87B |